Pharma Stocks
-
Is Mirum Pharmaceuticals (MIRM) Cheap As Leadership Changes Raise New Valuation Questions?
Mirum Pharmaceuticals (MIRM) has drawn fresh attention after appointing hepatologist Rob Myers, M.D., as Chief Medical Officer, replacing Joanne Quan,…
Read More » -
Piramal Pharma gets 7 observations from US FDA at Morpeth UK facility
Piramal Pharma Ltd on Monday (September 14) said the US Food and Drug Administration (FDA) issued a Form-483 with seven…
Read More » -
Dividend stocks alert, record date: Last chance to buy – Blue Dart, Karnataka Bank, Aarti Pharma, ITDC
Dividend alert, Sept. 14 — Shares of Blue Dart Express Limited, Karnataka Bank Limited, Aarti Pharmalabs Limited, Dilip Buildcon, Hexagon…
Read More » -
Ascletis Pharma (SEHK:1672) Following FDA Clearance Looks About Right At 3.8x P B
Ascletis Pharma (SEHK:1672) has kicked off a U.S. Phase I trial for its oral obesity candidate ASC36 after securing FDA…
Read More » -
Sunshine Lake Pharma (SEHK:6887) After Deepening Half Year Losses Looks Caught Between Value Signals
Sunshine Lake Pharma (SEHK:6887) just released half year results to June 30, 2026, reporting sales of CNY 1,075.31 million and…
Read More » -
Novo Nordisk (NVO) Stock Looks Like A Bargain At Current Prices
Novo Nordisk stock has gone through a harsh reset over the past few years, yet the current valuation checks still…
Read More » -
Bayer (XTRA:BAYN) Nears $7.25 Billion Roundup Hearing As FDA Clears New Lung Cancer Drug
Bayer (XTRA:BAYN) faces a final US court hearing on its proposed $7.25b Roundup settlement, seeking broad resolution of cancer suits.…
Read More » -
Bal Pharma Limited (NSE:BALPHARMA) Looks Interesting, And It’s About To Pay A Dividend
Bal Pharma Limited (NSE:BALPHARMA) is about to trade ex-dividend in the next three days. The ex-dividend date generally occurs two…
Read More » -
Jazz Pharmaceuticals (JAZZ) Wins On Ziihera Data, Is It Still 15% Below Fair Value?
Why Ziihera’s Phase 3 data matters for Jazz Pharmaceuticals Jazz Pharmaceuticals (JAZZ) is back in focus after fresh Phase 3…
Read More » -
How Lower Medicaid Prices At Astellas Pharma Stock Has Changed Its Investment Story
Astellas Pharma announced an agreement with the U.S. government to lower Medicaid drug prices and donate 25 kg of tacrolimus…
Read More »